Related Experiment Videos
The efficacy of the medical malpractice system: a Canadian perspective
1University of Alberta, Edmonton.
Annals of Health Law
|December 9, 1993
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Potent inhibition by ropivacaine of metastatic colon cancer SW620 cell invasion and NaV1.5 channel function.
British journal of anaesthesia·2014
Ileal pouch-anal anastomosis-vaginal fistula: a review.
Diseases of the colon and rectum·2005
Xenotransplantation: consent, public health and charter issues.
Medical law international·2003
Informed consent in Canada: an empirical study.
Osgoode Hall law journal·1984
An autoradiographic search for radioactive particles in the lungs of cigarette smokers.
Archives of environmental health·1980
Civil liability arising from "wrongful birth" following an unsuccessful sterilization operation.
American journal of law & medicine·1978
Federal/state tensions in fulfilling Medicaid's purpose.
Annals of health law·2012
New options to integrate care and financing for persons dually eligible for Medicare and Medicaid.
Annals of health law·2012
The challenges of reform for Medicaid managed care.
Annals of health law·2012
Post-reform Medicaid before the court: discordant advocacy reflects conflicting attitudes.
Annals of health law·2012
Polycation chain length determines the in vivo mRNA delivery efficiency of block copolymer micelles.
Biomaterials science·2026
Driving Drugs Deeper: Force-Driven Microneedle Systems for Active Therapy and Their Road Towards Clinical Implementation.
Small (Weinheim an der Bergstrasse, Germany)·2026
Mumio Potentiates Temozolomide by Inducing Apoptosis and Ferroptosis in Glioblastoma Cells.
Current pharmaceutical design·2026
Current Targeted Nanoparticle Therapy for Alzheimer's Disease: Current Advances and Future Prospects.
Current neurovascular research·2026
Clinical Presentation, Diagnosis, Treatment, and Outcome of Heart Disease in Becker Muscular Dystrophy.
Anatolian journal of cardiology·2026
Clinical Pharmacology of Eplontersen, the First Approved GalNAc-Conjugated Antisense Oligonucleotide.
Journal of clinical pharmacology·2026